Registration opens for Winship Scientific Symposium

The annual Winship Scientific Symposium, taking place virtually Dec. 2-3, will commemorate 50 years of the National Cancer Act and its continued impact on Winship Cancer Institute's pioneering research and discoveries. The symposium will include a keynote talk from Skip Trump, MD; scientific talks from faculty across Winship's four research programs; and a video poster session and oral abstracts showcasing student and trainee research. Video abstracts are due Nov. 15.

Winship awarded ACS Institutional Research Grant renewal

Winship's American Cancer Society Institutional Research Grant (ACS-IRG) has been renewed for another three years. The award, led by Larry Boise, PhD, provides funding for Winship's annual ACS-IRG pilot grants for early-career investigators.

About Winship's ACS-IRG

Meltzer receives AMA Distinguished Service Award

The American Medical Association (AMA) presented Carolyn C. Meltzer, MD, with the Distinguished Service Award. The award, one of the AMA’s highest honors, is given for meritorious service in the science and art of medicine.

Cooper profiled in CancerScope

Max D. Cooper, MD, is featured in a first person profile for CancerScope, published in the journal Cancer on Nov. 1. Cooper is credited with revolutionizing the understanding of the adaptive immune system through his discovery of B cells and T cells.

Kalinsky featured on the Weekly Check-Up Atlanta

Kevin Kalinsky, MD, discussed the importance of breast cancer screenings and partnering with the NFL for the Crucial Catch campaign on the Weekly Check-Up Atlanta, WSB radio's show with Bruce Feinberg, MD.

Listen to Episode

Baer featured on WABE's Closer Look

In an interview for WABE's “Closer Look," Wendy Baer, MD, spoke with host Rose Scott about the psychological toll that breast cancer takes on patients and family members, and offered strategies for how to cope.

Listen to Episode

Haynes interviewed on New England Biolabs podcast

Karmella Haynes, PhD, discussed synthetic biology and the future of epigenetic medicine in an interview with Lynn Morrison for the New England Biolabs podcast.

Listen to Episode

Call for applications: Assistant Dean for Novel Technology and Research Cores

The Assistant Dean for Novel Technology and Research Cores provides strategic and operational oversight for Emory's research infrastructure, core facilities, and other scientific initiatives. To apply, log in to hrprod.emory.edu, click 'Careers', and search for job number 79069.

Learn More

Call for proposals: Biolocity

The Biolocity program at Emory University and Georgia Tech Biolocity provides a combination of funding, project management, and consulting resources to early-stage technologies that address an unmet clinical need and have compelling commercial potential. Proposals are due Jan. 4, with a required technology screening discussion to be scheduled by Dec. 17.

Learn More

Call for nominations: Spirit of Winship Award

The Dell and Bobby Rearden Spirit of Winship Award recognizes Winship faculty, staff, and volunteers who demonstrate exemplary service, teamwork, and a commitment to the public good. Nominations for the annual awards are due Nov. 19.

Learn More

Veterans Day photo op

Each Veterans Day, Winship is proud to recognize and honor team members who have served in the U.S. armed forces. Join us for a photo op on Nov. 4 at 9 a.m. in the Vaughn-Jordan Healing Garden on the Clifton campus. Email Winship Communications with any questions.

Contact Communications

Below are four selected Winship publications out of 107 published over the past week:

Lonial S, Lee HC, Badros A, Trudel S, Nooka AK, Chari A, Abdallah AO, Callander N, Sborov D, Suvannasankha A, Weisel K, Voorhees PM, Womersley L, Baron J, Piontek T, Lewis E, Opalinska J, Gupta I, Cohen AD. Longer term outcomes with single-agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13-month follow-up from the pivotal DREAMM-2 study. Cancer. 2021; 127(22):4198-4212. PubMed PMID: 34314018.

View in PubMed

Tsementzi D, Meador R, Eng T, Patel P, Shelton J, Arluck J, Scott I, Dolan M, Khanna N, Konstantinidis KT, Bruner DW. Changes in the Vaginal Microbiome and Associated Toxicities Following Radiation Therapy for Gynecologic Cancers. Frontiers in Cellular and Infection Microbiology. 2021; 11:680038.

View in Journal

DuBois SG, Granger MM, Groshen S, Tsao-Wei D, Ji L, Shamirian A, Czarnecki S, Goodarzian F, Berkovich R, Shimada H, Villablanca JG, Vo KT, Pinto N, Mosse YP, Maris JM, Shusterman S, Cohn SL, Goldsmith KC, Weiss B, Yanik GA, Twist CJ, Irwin MS, Haas-Kogan DA, Park JR, Marachelian A, Matthay KK. Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients with Relapsed or Refractory Neuroblastoma: A Report from NANT Consortium. Journal of Clinical Oncology: official journal of the American Society of Clinical Oncology. 2021; 39(31):3506-3514. PubMed PMID: 34270348; PubMed Central PMCID: PMC8547934.

View in PubMed

Lamb LS, Pereboeva L, Youngblood S, Gillespie GY, Nabors LB, Markert JM, Dasgupta A, Langford C, Spencer HT. A combined treatment regimen of MGMT-modified γδ T cells and temozolomide chemotherapy is effective against primary high grade gliomas. Scientific Reports. 2021; 11(1):21133. PubMed PMID: 34702850.

View in PubMed